Synergistic Prosthetic Heart Valve System with Integrated AI, IoT, and Blockchain Technologies

A novel prosthetic heart valve system that integrates AI-based analytics, IoT-enabled sensors, and blockchain-based health record systems to enhance valve performance, predict potential failures, and optimize patient outcomes.

The original patent disclosed a pericardial sealing member for prosthetic heart valves, addressing the limitations of conventional prosthetic valves. However, the patent did not consider the potential benefits of integrating advanced technologies such as AI, IoT, and blockchain to further improve valve performance and patient care. The new inventive concept addresses this limitation by combining the pericardial sealing member with these distinct technologies to create a more powerful and effective system.

The synergistic prosthetic heart valve system comprises a prosthetic heart valve with a pericardial sealing member, an AI-based analytics module, an IoT-enabled sensor, and a blockchain-based health record system. The AI-based analytics module analyzes valve performance metrics detected by the IoT-enabled sensor and provides recommendations for valve optimization. The blockchain-based health record system securely stores the valve's unique identifier and corresponding health data, enabling secure and transparent tracking of patient health. The system can predict potential valve failures using machine learning-based predictive analytics, allowing for proactive maintenance and minimizing the risk of complications.

The new inventive concept's integration of AI, IoT, and blockchain technologies with the pericardial sealing member is novel and non-obvious compared to the original patent. The synergistic combination of these distinct technologies creates a more powerful and effective system that enhances valve performance, predicts potential failures, and optimizes patient outcomes.

Alternative embodiments of the inventive concept could include integrating the AI-based analytics module with other types of sensors, such as electrocardiogram or blood pressure sensors. Variations could also include using different blockchain platforms or incorporating additional features, such as remote software updates or patient engagement tools.

The synergistic prosthetic heart valve system has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular health and patient care. The system's ability to enhance valve performance, predict potential failures, and optimize patient outcomes could lead to improved health outcomes, reduced healthcare costs, and increased patient satisfaction.